临床生物标志物可区分脊髓炎与其他原因所致脊髓病
该研究在457例初诊为横贯性脊髓炎(TM)并转诊至脊髓病专科中心的患者中,分析临床表现、脊髓MRI和脑脊液特征,以评估初始临床与辅助检查特征对炎症性与非炎症性脊髓病的鉴别预测价值。结果仅247例(54%)最终确认为炎症性,其余46%为血管性(20%)、脊椎病性(8%)或其他脊髓病(18%)。症状时间特征、初始运动检查和MRI病灶分布可将正确分类率从67%提高至87%,其中症状时间特征贡献最大。
要点
- 初诊为横贯性脊髓炎的患者中仅54%最终确认为炎症性,46%为其他原因所致。
- 症状时间特征(超急性<6小时至慢性>21天)对鉴别的贡献最大。
- 确诊TM需批判性分析MRI与脑脊液特征以排除非炎症性脊髓病。
核心结论
- 症状时间特征可作为横贯性脊髓炎鉴别诊断中的临床生物标志物。
- 确诊TM需批判性分析MRI和脑脊液特征以排除非炎症性脊髓病原因。
研究设计与样本
- 研究纳入457例转诊至脊髓病专科中心、初诊为横贯性脊髓炎(TM)的患者,分析其临床表现、脊髓MRI和脑脊液特征。
- 采用多变量逻辑回归模型确定与最终诊断相关的特征及可改善分类准确性的预测因子。
- 证据等级为Class IV。
主要发现
- 457例初诊为TM的患者中,仅247例(54%)确认为炎症性;其余46%分别为血管性(20%)、脊椎病性(8%)或其他脊髓病(18%)。
- 预测模型纳入症状出现的时间特征、初始运动检查和MRI病灶分布后,正确分类率从67%提高至87%。
- 多分类曲线下面积(AUC)从0.32增至0.67;若仅考虑脑脊液细胞增多和MRI钆增强则未达此效果。
- 在所有预测因子中,症状时间特征对判别力提升的贡献最大。
关键数值与推荐
- 症状时间特征分层:超急性<6小时、急性6-48小时、亚急性48小时-21天、慢性>21天。
- 纳入时间特征、初始运动检查和MRI病灶分布后,正确分类率由67%升至87%。
- 多分类AUC由0.32升至0.67。
临床怎么用
- 对拟诊横贯性脊髓炎的患者,应详细记录症状出现的时间特征以辅助鉴别炎症性与非炎症性脊髓病。
- 结合初始运动检查与MRI病灶分布进行综合判断,并批判性分析MRI和脑脊液以排除血管性、脊椎病性等非炎症原因。
局限性
- 证据等级为Class IV。
- 本文摘要未报告单中心设计、回顾性与否及具体统计不确定性等局限信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the predictive value of the initial clinical and paraclinical features in the differentiation of inflammatory myelopathies from other causes of myelopathy in patients with initial diagnosis of transverse myelitis (TM). METHODS: We analyzed the clinical presentation, spinal cord MRI, and CSF features in a cohort of 457 patients referred to a specialized myelopathy center with the presumptive diagnosis of TM. After evaluation, the myelopathies were classified as inflammatory, ischemic/stroke, arteriovenous malformations/fistulas, spondylotic, or other. A multivariable logistic regression model was used to determine characteristics associated with the final diagnosis and predictors that would improve classification accuracy. RESULTS: Out of 457 patients referred as TM, only 247 (54%) were confirmed as inflammatory; the remaining 46% were diagnosed as vascular (20%), spondylotic (8%), or other myelopathy (18%). Our predictive model identified the temporal profile of symptom presentation (hyperacute <6 hours, acute 6-48 hours, subacute 48 hours-21 days, chronic >21 days), initial motor examination, and MRI lesion distribution as characteristics that improve the correct classification rate of myelopathies from 67% to 87% (multinomial area under the curve increased from 0.32 to 0.67), compared to only considering CSF pleocytosis and MRI gadolinium enhancement. Of all predictors, the temporal profile of symptoms contributed the most to the increased discriminatory power. CONCLUSIONS: The temporal profile of symptoms serves as a clinical biomarker in the differential diagnosis of TM. The establishment of a definite diagnosis in TM requires a critical analysis of the MRI and CSF characteristics to rule out non-inflammatory causes of myelopathy. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for patients presenting with myelopathy, temporal profile of symptoms, initial motor examination, and MRI lesion distribution distinguish those with inflammatory myelopathies from those with other causes of myelopathy.
引用
- Barreras P, Fitzgerald KC, Mealy MA, et al. Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy. Neurology. 2017. PMID: 29196574. doi:10.1212/WNL.0000000000004765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。